Start: September 4, 2018
End: September 30, 2023
This study will investigate whether changes in multiple lifestyle factors can help to slow down or reverse the progression of early Alzheimer's disease. Participants will be randomly assigned to a comparison group or a group that receives the intervention, which includes meals and supplements, a personalized exercise program, stress management activities, and group support for 20 weeks. The groups will then rotate for another 20 weeks. After each segment, the researchers will measure changes in cognition, gut bacteria, telomere length, levels of inflammation, cholesterol, blood pressure, and weight. Given COVID-19, the program is currently being delivered via videoconferencing.
Minimum Age: 45 Years
Maximum Age: 90 Years
Contact study personnel listed either under the general study contact or the location nearest you.
Lead: Preventive Medicine Research Institute
Source: ClinicalTrials.gov ID: NCT04606420